Joel F. Sussman insider trades

Open-market stock purchases and sales by Joel F. Sussman, Chief Accounting Officer at Galera Therapeutics, Inc, from SEC Form 4 filings since Jan 31, 2020.

Recent trades

DateStockTradeValue
Aug 3, 2026GRTX Galera Therapeutics, IncSold (not open market)$44K

Companies traded

  • GRTX Galera Therapeutics, Inc: 2 sales, last Aug 3, 2026

Get free alerts when Joel F. Sussman files a new trade →